Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes.
- 2026-05-15
- Review
- Diabetes, metabolic syndrome and obesity : targets and therapy 19
- Abdullatif Taha Babakr
- Mohammed Hasan Mukhtar
- Abeer Shaker Elmoursy Ali
- Mohammad A Althubiti
- Gad Allah Modawe
- Sameer Hasan Fatani
- Wesam A Nasif
- PubMed: 42163851
- DOI: 10.2147/dmso.s581925
- Low evidence
Chromium (Cr) supplementation significantly benefits individuals with chromium deficiency or diabetes, improving glucose homeostasis and insulin sensitivity.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes